- Stryker’s average annual return of 10.37% over the past 20 years has outperformed the market by 3.07% annually.
- The Fortune 500 medical technologies firm's deep-rooted consistency is a potent wealth multiplier, transforming an initial $100 investment into a significant pile.
Twenty years, a modest $100 investment and an average annual return rate of 10.37% - It seems like an all-too-simple formula, but these, in essence, are the elements that have contributed to Stryker's impressive performance in the stock market.
Firstly, we must give credit where it's due - The S&P 500, which is often considered a barometer for the U.S. stock market, has delivered reasonable returns over the past two decades. Nevertheless, it's Stryker (NYSE: SYK) that continues to boast the ability to consistently outperform the market, boasting a higher average annual return.
As one of the foremost medical technology companies globally, Stryker has garnered a following on Wall Street that reveres the stocks’ stellar 20-year track record. For our illustration, if you had invested $100 into Stryker's stock 20 years ago, you would now be sitting on a cache that’s exponentially more valuable. This valuation grows even more impressive when we look at Stryker's current market capitalization - a staggering $104.10 billion.
Comments